Salma Health delivers end-to-end brain health care by uniting psychiatry, neurology, psychology, crisis services, and clinical research under one roof. Its specially equipped clinics offer treatments such as conventional and accelerated TMS, SAINT neuromodulation, esketamine therapy, psychotherapy, and pharmacotherapy, all personalized via rigorous clinical assessments. The company operates locations in San Diego, Orange County, Fremont, and Berkeley and intends to expand nationally. Complementing in-person care, Salma Health runs telehealth services and an FDA-regulated clinical trial platform that partners with pharmaceutical and medical-device firms. Central to its model is an AI-powered “Brain Health OS” that integrates clinical data to support precision diagnostics, outcome tracking, and care coordination. Deep patient profiling across neural, physiological, and digital markers generates a comprehensive dataset meant to drive predictive models and real-world evidence. By publishing outcomes and collaborating with health systems and regulators, Salma Health aims to set new clinical guidelines and advance personalized brain healthcare.

Total raised

$80M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2026